Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$0.62 - $0.85 $1,361 - $1,866
-2,196 Reduced 3.76%
56,202 $47,000
Q4 2023

Feb 13, 2024

BUY
$0.67 - $1.35 $292 - $588
436 Added 0.75%
58,398 $40,000
Q3 2023

Nov 13, 2023

BUY
$1.02 - $1.23 $2,101 - $2,533
2,060 Added 3.69%
57,962 $61,000
Q2 2023

Aug 04, 2023

BUY
$1.04 - $1.4 $58,138 - $78,262
55,902 New
55,902 $62,000
Q2 2022

Aug 12, 2022

SELL
$0.67 - $1.4 $30,620 - $63,982
-45,702 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$1.23 - $3.31 $3,954 - $10,641
-3,215 Reduced 6.57%
45,702 $56,000
Q4 2021

Feb 11, 2022

SELL
$2.89 - $4.43 $2,271 - $3,481
-786 Reduced 1.58%
48,917 $159,000
Q3 2021

Nov 12, 2021

SELL
$3.36 - $4.62 $1,169 - $1,607
-348 Reduced 0.7%
49,703 $207,000
Q2 2021

Aug 13, 2021

BUY
$2.82 - $5.01 $29,688 - $52,745
10,528 Added 26.64%
50,051 $209,000
Q1 2021

May 07, 2021

BUY
$2.92 - $5.07 $303 - $527
104 Added 0.26%
39,523 $179,000
Q4 2020

Feb 12, 2021

SELL
$1.64 - $3.42 $1,854 - $3,868
-1,131 Reduced 2.79%
39,419 $119,000
Q3 2020

Nov 04, 2020

SELL
$2.18 - $2.84 $2,012 - $2,621
-923 Reduced 2.23%
40,550 $101,000
Q2 2020

Aug 12, 2020

BUY
$1.83 - $4.06 $75,895 - $168,380
41,473 New
41,473 $118,000
Q2 2019

Aug 13, 2019

SELL
$1.79 - $3.05 $39,047 - $66,532
-21,814 Closed
0 $0
Q1 2019

May 06, 2019

BUY
$1.47 - $3.06 $14,644 - $30,483
9,962 Added 84.05%
21,814 $52,000
Q4 2018

Feb 13, 2019

SELL
$2.66 - $15.93 $242 - $1,449
-91 Reduced 0.76%
11,852 $32,000
Q3 2018

Nov 09, 2018

BUY
$12.07 - $16.0 $2,595 - $3,440
215 Added 1.83%
11,943 $186,000
Q2 2018

Aug 08, 2018

BUY
$9.36 - $13.25 $25,487 - $36,079
2,723 Added 30.24%
11,728 $155,000
Q1 2018

May 07, 2018

SELL
$8.49 - $11.82 $3,166 - $4,408
-373 Reduced 3.98%
9,005 $92,000
Q4 2017

Feb 09, 2018

BUY
$8.97 - $23.38 $13,643 - $35,560
1,521 Added 19.36%
9,378 $92,000
Q3 2017

Nov 09, 2017

BUY
$15.22 - $20.03 $119,583 - $157,375
7,857
7,857 $143,000

Others Institutions Holding SELB

About SELECTA BIOSCIENCES INC


  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.